Principles and Methods of Statistical Assessment of Abuse-Deterrent Opioids Ling Chen Biostatistics: Original Research 30 December 2018 Pages: 7 - 13
Statistical Interactions in a Clinical Trial Naitee Ting Biostatistics: Original Research 30 December 2018 Pages: 14 - 21
New Benchmarks Characterizing Growth in Protocol Design Complexity Kenneth A. GetzRafael A. Campo Clinical Trials: Original Research 30 December 2018 Pages: 22 - 28
Industry and Patient Perspectives on Child Participation in Clinical Trials: The Pediatric Assent Initiative Survey Report Donald LombardiLiza SquiresCharles Thompson Clinical Trials: Original Research 30 December 2018 Pages: 29 - 37
Comparative User Testing of Australian and UK Over-the-Counter Labels and Leaflets for Diclofenac Vivien TongDavid K. RaynorParisa Aslani Global Perspectives: Original Research 30 December 2018 Pages: 38 - 48
Industry Perspective of Pediatric Drug Development in the United States: Involvement of the European Union Countries Taku OnishiKatsura TsukamotoTakashi Waki Global Perspectives: Original Research 30 December 2018 Pages: 49 - 56
Medical Science Liaisons in Real-World Evidence Studies: Experience of AstraZeneca Russia Nikolay SuvorovVera KarasevaVladimir Bulatov Global Perspectives: Original Research 30 December 2018 Pages: 57 - 61
A Comparative Study of Medical Device Regulations: US, Europe, Canada, and Taiwan Yi-Jung ChenChi-Ming ChiouChia-Hung Chien Global Perspectives: Review 30 December 2018 Pages: 62 - 69
Medical Writing Competency Model — Section 1: Functions, Tasks, and Activities David B. ClemowBertil WagnerYumiko Aoyama Medical Communications: Analytical Report 30 December 2018 Pages: 70 - 77
Medical Writing Competency Model — Section 2: Knowledge, Skills, Abilities, and Behaviors David B. ClemowBertil WagnerYumiko Aoyama Medical Communications: Analytical Report 30 December 2018 Pages: 78 - 88
Evolution of Drug Development: Integrating the Patient Perspective Into Early Research Anthony J. YanniJennifer Fine Patient Engagement: Original Research 30 December 2018 Pages: 89 - 93
Pharmacotherapeutic Reports as Tools for Detecting Discrepancies in Continuity of Care Elena Yaiza Romero-VentosaMónica Gayoso-ReyGuadalupe Piñeiro-Corrales Pharmacotherapeutics: Original Research 30 December 2018 Pages: 94 - 99
Neonatal Safety Information Reported to the FDA During Drug Development Studies Debbie AvantGerri BaerJian Wang Product Safety: Original Research 30 December 2018 Pages: 100 - 108
Adverse Reactions to Radiopharmaceuticals: A Survey Based on Clinical Cases Using Criteria of Systematic Review Suyene Rocha PintoLuis Filipe Cavalcanti SantosRalph Santos-Oliveira Product Safety: Review 30 December 2018 Pages: 109 - 113
Evaluation of Risk Versus Benefit Information in Direct-To-Consumer (DTC) Prescription Drug Television Advertisements Germin FahimMichael ToscaniShivani Gandhi Regulatory Science: Review 30 December 2018 Pages: 114 - 117
Development of Prescription Drug Information Leaflets: Impact of Cognitive Effort and Patient Involvement on Prescription Medication Information Processing Harshali K. PatelShweta S. BapatSujit S. Sansgiry Regulatory Science: Original Research 30 December 2018 Pages: 118 - 129